On-Demand: How to Fast-Track Innovation While Addressing CMC Challenges in Expedited Approval Pathways
23 December 2025
Overview
Robert Cornog, Senior Director (Product Development) explores the critical role of expedited review pathways in accelerating the development and approval of new therapies.
Key takeaways
- Understand the different expedited review pathways, their requirements, and strategic considerations for leveraging these in drug development
- Identify CMC challenges and solutions in managing compressed development timelines
- Gain insights into real-world applications and success stories of expedited pathways
Watch our on-demand webinar recording.